Avandamet Bioequivalence Study Brazil - Fed Administration
Status:
Completed
Trial end date:
2009-12-06
Target enrollment:
Participant gender:
Summary
The study is prospective, open-label, randomized, crossover, with 02 treatments, 02
sequences, and 02 periods. The volunteers received, in each period, the reference or the test
formulation after standardized meals.